Ionis Pharmaceuticals (NASDAQ: IONS) reported Q3 EPS of ($0.58), $0.08 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $133 million versus the consensus estimate of $161.63 million.

For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.